These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2579198)
21. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet. Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091 [TBL] [Abstract][Full Text] [Related]
22. PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain. Mach RH; Ehrenkaufer RL; Greenberg JH; Shao L; Morton TE; Evora PH; Nowak PA; Luedtke RR; Cohen D; Reivich M Synapse; 1995 Mar; 19(3):177-87. PubMed ID: 7784958 [TBL] [Abstract][Full Text] [Related]
23. Neuroleptic binding sites: specific labeling in mice with [18F]haloperidol, a potential tracer for positron emission tomography. Zanzonico PB; Bigler RE; Schmall B J Nucl Med; 1983 May; 24(5):408-16. PubMed ID: 6132964 [TBL] [Abstract][Full Text] [Related]
24. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro]. Oelssner W; Peinhardt G; Büge A Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832 [TBL] [Abstract][Full Text] [Related]
26. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET. Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193 [TBL] [Abstract][Full Text] [Related]
27. Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; radiopharmaceuticals for PET studies of dopamine receptors. Welch MJ; Chi DY; Mathias CJ; Kilbourn MR; Brodack JW; Katzenellenbogen JA Int J Rad Appl Instrum B; 1986; 13(5):523-6. PubMed ID: 3818316 [TBL] [Abstract][Full Text] [Related]
29. No-carrier-added (NCA) (+/-)-N-(3-[18F]fluoropropyl)-N-normetazocine-synthesis and PET studies in a baboon. Shiue CY; Teng RR; Bai LQ; Wolf AP; Arnett CD; Simon EJ Int J Rad Appl Instrum B; 1987; 14(2):119-22. PubMed ID: 3496324 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vivo evaluation of [18F]-N-(p-nitrobenzyl)spiperone ([18F]PNBS) in rats. Mach RH; Nowak PA; Moroney DA; Morton TE; Jackson JR; Ehrenkaufer RL Nucl Med Biol; 1993 Apr; 20(3):269-78. PubMed ID: 8485486 [TBL] [Abstract][Full Text] [Related]
32. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding. Moerlein SM; Banks WR; Parkinson D Int J Rad Appl Instrum A; 1992 Jul; 43(7):913-7. PubMed ID: 1321101 [TBL] [Abstract][Full Text] [Related]
33. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain. Pedigo NW; Reisine TD; Fields JZ; Yamamura HI Eur J Pharmacol; 1978 Aug; 50(4):451-3. PubMed ID: 699968 [No Abstract] [Full Text] [Related]
34. A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET. Fowler JS; Arnett CD; Wolf AP; Shiue CY; MacGregor RR; Halldin C; Långström B; Wagner HN Int J Rad Appl Instrum B; 1986; 13(3):281-4. PubMed ID: 3771261 [TBL] [Abstract][Full Text] [Related]
35. In vivo stereospecific [3H]spiperone binding in rat brain: characteristics, regional distribution, kinetics and pharmacological properties. Barone D; Luzzani F; Assandri A; Galliani G; Mennini T; Garattini S Eur J Pharmacol; 1985 Oct; 116(1-2):63-74. PubMed ID: 4054217 [TBL] [Abstract][Full Text] [Related]
36. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding. Moerlein SM; Perlmutter JS; Markham J; Welch MJ J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581 [TBL] [Abstract][Full Text] [Related]
37. In vivo modulation of brain dopamine recognition sites: a possible model for emission computed tomography studies. Ferrero P; Vaccarino F; Guidotti A; Costa E; Di Chiro G Neuropharmacology; 1983 Jun; 22(6):791-5. PubMed ID: 6604240 [TBL] [Abstract][Full Text] [Related]
38. Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidol. Schlyer DJ; Volkow ND; Fowler JS; Wolf AP; Shiue CY; Dewey SL; Bendriem B; Logan J; Raulli R; Hitzemann R Synapse; 1992 May; 11(1):10-9. PubMed ID: 1604422 [TBL] [Abstract][Full Text] [Related]
39. Computer-assisted video analysis of [3H]spiroperidol binding autoradiographs. Altar CA; Walter RJ; Neve KA; Marshall JF J Neurosci Methods; 1984 Mar; 10(3):173-88. PubMed ID: 6738107 [TBL] [Abstract][Full Text] [Related]
40. Characteristics of specific in vivo labeling of neuroleptic binding sites with 3-N-[11C]methylspiperone. Yanai K; Ido T; Ishiwata K; Hatazawa J; Watanuki S; Takahashi T; Ujiie A; Ito M; Matsuzawa T Eur J Nucl Med; 1986; 11(11):438-43. PubMed ID: 3486764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]